Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
77°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about TAK
Recent news which mentions TAK
< Previous
1
2
3
4
5
6
7
Next >
Seagen's Adcetris/Immunotherapy Combo Achieves 98% Overall Response Rate in Early-Stage Lymphoma Setting
June 13, 2023
Tickers
SGEN
TAK
Tags
Benzinga
Health Care
TAK
From
Benzinga
3 Stocks That Could Skyrocket by This Time Next Summer
June 08, 2023
Tickers
CELH
MNSO
MNST
MORF
Tags
PEP
Market News
MORF
From
InvestorPlace
Why Shares of Innate Pharma Jumped Thursday
June 08, 2023
Tickers
IPHA
SNY
TAK
Tags
SNY
IPHA
Market News
From
Motley Fool
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
May 19, 2023
Tickers
ABBV
JNJ
TAK
Tags
Market News
General
FDA
From
Benzinga
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
May 11, 2023
Tickers
TAK
TBPH
TKPHF
Tags
TKPHF
News
Health Care
From
Benzinga
Earnings Scheduled For May 11, 2023
May 11, 2023
Tickers
RAIN
RCEL
REAX
RGTI
Tags
SSIC
VRME
TNK
From
Benzinga
Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues
May 11, 2023
Tickers
TAK
TKPHF
Tags
why it's moving
Market News
News
From
Benzinga
Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More
April 25, 2023
Tickers
CBD
KHRNF
MRMD
PEP
Tags
Jacqueline Jacques
Movers & Shakers
SHFS
From
Benzinga
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
April 25, 2023
Tickers
AMGN
ARWR
GSK
TAK
Tags
ARWR
Market News
AMGN
From
Motley Fool
This Supercharged Dividend King Stock Might Soon Run Out of Steam
April 25, 2023
Tickers
ABBV
ABT
BMY
GILD
Tags
VRTX
ABT
PFE
From
Motley Fool
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
Tickers
GSK
MRK
SNY
TAK
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 11, 2023
Tickers
AGFY
AMC
BNRG
CLEU
Tags
JFBR
CNTG
AMC
From
InvestorPlace
Etsy To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
April 04, 2023
Tickers
AVAV
AXP
DHR
ETSY
Tags
Small Cap
PVH
AVAV
From
Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
March 20, 2023
Tickers
BMY
TAK
TKPHF
Tags
Analyst Ratings
BMY
Analyst Color
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
March 16, 2023
Tickers
ALG
BBLN
CHH
DINO
Tags
ALG
Intraday Update
LOAN
From
Benzinga
Johnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies
March 15, 2023
Tickers
JNJ
TAK
Tags
Market News
General
Benzinga
From
Benzinga
Should You Give Up on Novavax?
March 03, 2023
Tickers
MRNA
NVAX
PFE
TAK
Tags
MRNA
NVAX
Market News
From
Motley Fool
2 Incredibly Cheap High-Yield Dividend Stocks to Buy Now
February 28, 2023
Tickers
F
TAK
Tags
TAK
Recent Press Releases
Market News
From
Motley Fool
Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients
February 21, 2023
Tickers
TAK
TKPHF
Tags
Market News
General
TAK
From
Benzinga
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
Tickers
MRNA
NVAX
PFE
TAK
Tags
NVAX
Market News
MRNA
From
Motley Fool
Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged
February 02, 2023
Tickers
TAK
TKPHF
Tags
Eurasia
General
Benzinga
From
Benzinga
7 Sorry Dividend Stocks to Sell in February Before It’s Too Late
January 30, 2023
Tickers
BIG
CPB
CWH
D
Tags
Market News
CPB
D
From
InvestorPlace
Finch Therapeutics Halts Work On Its Only Clinical Stage Asset, Cuts 95% Of Workforce
January 24, 2023
Tickers
FNCH
TAK
Tags
Market News
General
Health Care
From
Benzinga
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
January 23, 2023
Tickers
HCM
TAK
Tags
why it's moving
Contracts
Market News
From
Benzinga
Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study
January 09, 2023
Tickers
ARWR
TAK
TKPHF
Tags
ARWR
Market News
Trading Ideas
From
Benzinga
A Bullish Sign Appears On Takeda Pharmaceutical's Chart
December 28, 2022
Tickers
TAK
Tags
BZI/CROSS
Market News
Markets
From
Benzinga
Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies
December 14, 2022
Tickers
DCPH
PFE
TAK
THRX
Tags
Initiation
Analyst Ratings
Market News
From
Benzinga
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
Tickers
TAK
TKPHF
Tags
Benzinga
Movers
Biotech
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
Market News
General
IPSEY
From
Benzinga
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
November 30, 2022
Tickers
AMZN
ARE
BMY
LLY
Tags
UBER
SLG
SNY
From
Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.